Exploring how isoniazid-containing metal-based drugs offer innovative solutions to antimicrobial resistance through enhanced efficacy and novel mechanisms of action.
Exploring the groundbreaking benzimidazole-quinoline hybrids that are transforming cancer and antimicrobial therapy through dual-action mechanisms.